NCT03316456View on ClinicalTrials.gov

Gut Microbiota in Intestinal Barrier Damage in Acute Leukemia Patients Undergoing Inpatient Induction

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

August 22, 2017

Primary Completion Date

December 26, 2017

Study Completion Date

April 1, 2019

Conditions
Chemotherapy-Induced Gut Barrier DamageAcute Leukemia
Interventions
DIAGNOSTIC_TEST

Observational: Stool Sample Collection

"Observational: Stool Sample Collection~\- Samples will be collected on the day of the first dose of chemotherapy, then subsequently every Monday, Wednesday, Friday until Day 28 of chemotherapy, death, or discharge from the hospital, whichever occurs sooner."

DIAGNOSTIC_TEST

Observational: Blood Sample Collection

"Observational: Blood Sample Collection~\- Samples will be collected on the day of the first dose of chemotherapy, then subsequently every Monday, Wednesday, Friday until Day 28 of chemotherapy, death, or discharge from the hospital, whichever occurs sooner."

DIAGNOSTIC_TEST

Observational: Urine Sample Collection

"Observational: Urine Sample Collection~\- Samples will be collected on the day of the first dose of chemotherapy, then subsequently every Monday, Wednesday, Friday until Day 28 of chemotherapy, death, or discharge from the hospital, whichever occurs sooner."

Trial Locations (1)

55455

Masonic Cancer Center at University of Minnesota, Minneapolis

All Listed Sponsors
lead

Masonic Cancer Center, University of Minnesota

OTHER

NCT03316456 - Gut Microbiota in Intestinal Barrier Damage in Acute Leukemia Patients Undergoing Inpatient Induction | Biotech Hunter | Biotech Hunter